Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

2.

Paroxetine use in medically ill patients.

Stout SS, Somerset WI, Miller A, Musselman DL.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:108-22. Review.

PMID:
14566206
3.

Focus on paroxetine.

Green B.

Curr Med Res Opin. 2003;19(1):13-21. Review.

PMID:
12661775
4.

Paroxetine.

Tang SW, Helmeste D.

Expert Opin Pharmacother. 2008 Apr;9(5):787-94. doi: 10.1517/14656566.9.5.787 . Review.

PMID:
18345955
5.

Paroxetine: a review.

Bourin M, Chue P, Guillon Y.

CNS Drug Rev. 2001 Spring;7(1):25-47. Review.

6.

Paroxetine in the treatment of generalised anxiety disorder.

Snyderman SH, Rynn MA, Bellew K, Rickels K.

Expert Opin Pharmacother. 2004 Aug;5(8):1799-806. Review.

PMID:
15264994
7.

A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?

Sanchez C, Reines EH, Montgomery SA.

Int Clin Psychopharmacol. 2014 Jul;29(4):185-96. doi: 10.1097/YIC.0000000000000023. Review.

8.

[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].

Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.

Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Review. French.

PMID:
20513456
9.

Paroxetine for the treatment of depression: a critical update.

Gibiino S, Serretti A.

Expert Opin Pharmacother. 2012 Feb;13(3):421-31. doi: 10.1517/14656566.2012.652085. Epub 2012 Jan 21. Review.

PMID:
22263916
10.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.

Clin Ther. 2007 May;29(5):918-926. doi: 10.1016/j.clinthera.2007.05.003. Review.

PMID:
17697910
11.

Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.

Gentile S, Bellantuono C.

J Clin Psychiatry. 2009 Mar;70(3):414-22. Epub 2009 Feb 24. Review.

PMID:
19254517
12.

[Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].

Bryois C, Rubin C, Zbinden JD, Baumann P.

Praxis (Bern 1994). 1998 Mar 4;87(10):345-8. Review. French.

PMID:
9545842
13.

Clinical management of perinatal depression: focus on paroxetine.

Newport DJ, Stowe ZN.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:148-66. Review.

PMID:
14566197
14.

Paroxetine: a review of clinical experience.

Dunner D, Kumar R.

Pharmacopsychiatry. 1998 May;31(3):89-101. Review.

PMID:
9657236
15.

Paroxetine versus other anti-depressive agents for depression.

Purgato M, Papola D, Gastaldon C, Trespidi C, Magni LR, Rizzo C, Furukawa TA, Watanabe N, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2014 Apr 3;(4):CD006531. doi: 10.1002/14651858.CD006531.pub2. Review.

PMID:
24696195
16.

Paroxetine treatment of depression in late life.

Reynolds CF 3rd.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:123-34. Review.

PMID:
14566207
17.

Did regulators fail over selective serotonin reuptake inhibitors?

Healy D.

BMJ. 2006 Jul 8;333(7558):92-5. Review. No abstract available.

18.

Substance P in depression.

Salzman C.

Harv Ment Health Lett. 2001 Dec;18(6):7. Review. No abstract available.

PMID:
11751091
19.

Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.

Bourin M.

Hum Psychopharmacol. 2003 Apr;18(3):185-90. Review.

PMID:
12672169
20.

SSRI discontinuation syndrome following bariatric surgery: a case report and focused literature review.

Bingham K, Hawa R, Sockalingam S.

Psychosomatics. 2014 Nov-Dec;55(6):692-7. doi: 10.1016/j.psym.2014.07.003. Epub 2014 Jul 15. Review. No abstract available.

PMID:
25497508

Supplemental Content

Support Center